drugset / Trial / NCT03245333
A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)
Phase 3
Unknown
120 enrolled
Changchun GeneScience Pharmaceutical Co., Ltd.
Beijing Children's Hospital · collabShanghai Children's Hospital · collabThe Children's Hospital of Zhejiang University School of Medicine · collabThe First Affiliated Hospital with Nanjing Medical University · collabTongji Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
According to the results of the phase II study, choose the best dose of JINTOPIN AQ for short SGA children, further to evaluate the efficacy and safety of the treatment of short SGA children.
Timeline
- Start
- 2014-12
- Primary completion
- 2017-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.2 iu/kg | — |